French beauty giant L’Oréal is in advanced negotiations to acquire a majority stake in Innovist, the fast-growing Indian beauty and personal care company behind brands such as Bare Anatomy, Chemist at Play, Sunscoop, and Vinci Botanicals. The deal, reportedly valued between $350–450 million (₹4,000 crore), is said to be in its final stages after nearly a year of discussions.
L’Oréal has largely grown organically in India since entering in 1994, focusing on brands like Garnier, Maybelline, and L’Oréal Paris.
The Innovist deal would mark one of its largest direct acquisitions in India’s consumer startup space, surpassing Hindustan Unilever’s ₹3,000 crore Minimalist buy.
About Innovist
Founded in 2019 in Gurugram by Rohit Chawla, Sifat Khurana, Vimal Bhola, and Velmurugan S. Sivappraghassan, Innovist has positioned itself as a digital-first, science-backed beauty and personal care platform. Its portfolio spans personalized haircare, skincare, sun protection, and botanical-based products, catering to India’s rapidly evolving consumer preferences for sustainable and effective solutions.Investors
- Point72 Ventures
- Accel
- ICICI Venture
Strategic Rationale
- Strengthen L’Oréal’s India growth strategy, especially after slowing to ~5% last year.
- Provide access to digitally native brands that resonate with younger consumers.
- Expand footprint in personalized and science-driven beauty segments.
- Represents a potential landmark exit for Innovist’s founding team.
Quick Snapshot
| Aspect | Details |
|---|---|
| Target | Innovist (Bare Anatomy, Chemist at Play, Sunscoop, Vinci Botanicals) |
| Buyer | L’Oréal India |
| Deal Value | $350–450M (~₹4,000 crore) |
| Founders | Rohit Chawla, Sifat Khurana, Vimal Bhola, Velmurugan S. Sivappraghassan |
| Investors | Point72 Ventures, Accel, ICICI Venture |
| Stage | Final negotiation phase |
L’Oréal’s Acquisitions in Asia
Kering’s Beauty Portfolio (2025)- L’Oréal acquired the beauty licenses of Gucci, Saint Laurent, Balenciaga, and other Kering fashion houses.
- Deal size: ~$4.5 billion.
- Impact: Strengthened L’Oréal’s luxury segment in Asia, adding high‑end fragrance and cosmetics lines to its portfolio.
- L’Oréal has historically acquired niche skincare and haircare brands across Asia to tap into local consumer trends.
- Examples include investments in Chinese and Southeast Asian beauty startups, though most of its large‑scale acquisitions have been global luxury portfolios integrated into Asian markets.
Snapshot Table
| Region | Acquisition | Year | Value | Strategic Impact |
|---|---|---|---|---|
| India | Innovist (Bare Anatomy, Chemist at Play, Sunscoop, Vinci Botanicals) | 2026 (talks ongoing) | $350–450M (~₹4,000 crore) | Boost digital‑first, science‑backed beauty in India |
| Asia (Luxury) | Kering’s Beauty Portfolio (Gucci, Saint Laurent, Balenciaga) | 2025 | ~$4.5B | Strengthen luxury beauty presence in Asia |
| China & SE Asia | Smaller skincare/haircare brand acquisitions | Various | Not disclosed | Localized product innovation, market penetration |
Key Takeaways
- India: Innovist would be L’Oréal’s biggest bet in India, signaling a pivot toward D2C and personalized beauty.
- Asia: The Kering portfolio acquisition cements L’Oréal’s dominance in luxury beauty, crucial for markets like China, Japan, and Southeast Asia.
- Strategy: L’Oréal balances mass‑market growth in India with luxury expansion in Asia, ensuring coverage across consumer segments.
IndianWeb2.com is an independent digital media platform for business, entrepreneurship, science, technology, startups, gadgets and climate change news & reviews.
No comments
Post a Comment